These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16327340)

  • 1. Adherence without access to antiretroviral therapy in sub-Saharan Africa?
    Bangsberg DR; Ware N; Simoni JM
    AIDS; 2006 Jan; 20(1):140-1; author reply 141-2. PubMed ID: 16327340
    [No Abstract]   [Full Text] [Related]  

  • 2. Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'.
    Harries AD; Makombe SD; Schouten EJ; Ben-Smith A; Jahn A
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):310-1. PubMed ID: 18316103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional health practitioners are key to scaling up comprehensive care for HIV/AIDS in sub-Saharan Africa.
    Homsy J; King R; Balaba D; Kabatesi D
    AIDS; 2004 Aug; 18(12):1723-5. PubMed ID: 15280784
    [No Abstract]   [Full Text] [Related]  

  • 4. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa.
    Gill CJ; Hamer DH; Simon JL; Thea DM; Sabin LL
    AIDS; 2005 Aug; 19(12):1243-9. PubMed ID: 16052078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does early ART in sub-Saharan Africa decrease mortality?
    Katz IT; Siedner MJ
    Lancet HIV; 2015 Sep; 2(9):e354-5. PubMed ID: 26423540
    [No Abstract]   [Full Text] [Related]  

  • 7. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.
    Mills EJ; Nachega JB; Buchan I; Orbinski J; Attaran A; Singh S; Rachlis B; Wu P; Cooper C; Thabane L; Wilson K; Guyatt GH; Bangsberg DR
    JAMA; 2006 Aug; 296(6):679-90. PubMed ID: 16896111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
    Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
    J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
    Ojikutu B; Jack C; Ramjee G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S523-7. PubMed ID: 18181705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO guidelines for antiretroviral therapy in serodiscordant couples in sub-Saharan Africa: how many fit?
    Kouamé G; Danel C; Moh R; Badjé A; Jean K; N'takpe JB; Gabillard D; Le Carrou J; du Loû AD; Deschamps N; Eholie S; Anglaret X
    AIDS; 2014 Jun; 28(10):1533-5. PubMed ID: 24804862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defaulting from antiretroviral treatment programmes in sub-Saharan Africa: a problem of definition.
    Grimsrud A; Ford N; Myer L
    Trop Med Int Health; 2011 Mar; 16(3):390-1; author reply 392. PubMed ID: 21143352
    [No Abstract]   [Full Text] [Related]  

  • 13. Universal access to antiretroviral therapy: when, not if.
    Carpenter CC
    Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography.
    Merten S; Kenter E; McKenzie O; Musheke M; Ntalasha H; Martin-Hilber A
    Trop Med Int Health; 2010 Jun; 15 Suppl 1():16-33. PubMed ID: 20586957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.
    Reid SE; Reid CA; Vermund SH
    Int J STD AIDS; 2004 Nov; 15(11):713-6. PubMed ID: 15537453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.
    Inzaule SC; Ondoa P; Peter T; Mugyenyi PN; Stevens WS; de Wit TFR; Hamers RL
    Lancet Infect Dis; 2016 Nov; 16(11):e267-e275. PubMed ID: 27569762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing antiretroviral anarchy in sub-Saharan Africa.
    Harries AD; Nyangulu DS; Hargreaves NJ; Kaluwa O; Salaniponi FM
    Lancet; 2001 Aug; 358(9279):410-4. PubMed ID: 11502341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
    Badri M; Cleary S; Maartens G; Pitt J; Bekker LG; Orrell C; Wood R
    Antivir Ther; 2006; 11(1):63-72. PubMed ID: 16518961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Logistics and models of implementing large-scale HIV treatment, care and support in Africa.
    Darkoh-Ampem E; Sargent J; Butler J
    J HIV Ther; 2006 Mar; 11(1):16-20. PubMed ID: 16706251
    [No Abstract]   [Full Text] [Related]  

  • 20. Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.
    Peterson K; van Griensven J; Huis in 't Veld D; Colebunders R
    Expert Rev Anti Infect Ther; 2012 Jan; 10(1):43-50. PubMed ID: 22149613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.